touchPODCAST

MDT and patient perspectives on the importance of treatment intensification, weight loss, and education in T2D and obesity

touchMDT for touchENDOCRINOLOGY

Listen to key experts from a multidisciplinary team and a patient discuss the benefits of early treatment intensification and weight loss for patients with T2D and obesity as well as the importance of effective patient education strategies. 

The multidisciplinary team and patient

• Diabetes care & education specialist: Ms Jennifer Okemah, Kirkland, WA
• Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
• Patient: Ms Brittany Jones, Atlanta, GA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/

MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity

touchMDT for touchENDOCRINOLOGY

Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development

The multidisciplinary team and patient

• Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
• Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
• Patient: Ms Brittany Jones, Atlanta, GA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/touchENDOCRINOLOGY

MDT perspectives on the role of incretin hormones in wellness and in T2D

touchMDT for touchENDOCRINOLOGY

Listen to key experts from a multidisciplinary team discuss the role of incretin hormones in healthy individuals and in those with T2D and share insights from the latest research in this field 

The multidisciplinary team

• Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
• Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

For further information visit: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/

Targeting the pathobiology of ESCC: Potential impact of immunotherapy on clinical practice

touchEXPERT OPINIONS for touchONCOLOGY

Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies.

The experts

• Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Dr Jean-Phillippe Metges, Brest University Hospital, Brest, France
• Dr Radka Obermannova, Masaryk Memorial Cancer Institute Brno, Czech Republic

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from from Novartis. This activity is provided by touchIME.

For further information visit our website: https://touchoncologyime.org/targeting-pathobio-of-ESCC-and-emerging-impact-of-IO

The evolving role of antibody–drug conjugates in the treatment of urothelial carcinoma

Listen to a genitourinary cancer expert outline the use of antibody–drug conjugates in the treatment of urothelial carcinoma, including their place in current treatment guidelines, clinical trial data and the management of possible adverse events.

The expert

• Dr Cora Sternberg, Weill Cornell Medicine, New York, NY, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Gilead Sciences and Seagen. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/antibody-drug-conjugates-in-urothelial-carcinoma/

MDT and patient perspectives on the long-term management of patients with severe type 2 asthma

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma. 

The multidisciplinary team 

• Pulmonologist: Professor Alberto Papi, Italy
• Allergist: Professor Ioana Agache, Romania
• Primary care physician: Professor Barbara Yawn, USA
• Patient: Ms JoJo O’Neal, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/

MDT and patient perspectives on the disease burden of severe asthma

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families.

The multidisciplinary team

• Primary care physician: Professor Barbara Yawn, USA
• Allergist: Professor Ioana Agache, Romania
• Patient: Ms JoJo O’Neal, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//

MDT perspectives on biologic treatment selection in severe type 2 asthm

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.

The multidisciplinary team 

• Allergist: Professor Ioana Agache, Romania
• Primary care physician: Professor Barbara Yawn, USA
• Pulmonologist: Professor Alberto Papi, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/

MDT and patient perspectives on the disease burden of severe asthma

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families.

The multidisciplinary team

• Primary care physician: Professor Barbara Yawn, USA
• Allergist: Professor Ioana Agache, Romania
• Patient: Ms JoJo O’Neal, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/

MDT perspectives on biologic treatment selection in severe type 2 asthma

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.

The multidisciplinary team 

• Allergist: Professor Ioana Agache, Romania
• Primary care physician: Professor Barbara Yawn, USA
• Pulmonologist: Professor Alberto Papi, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//